Global Virtual Healthcare Expo (GVHE)

  • Global Virtual Healthcare Expo

With Covid – 19 disrupting normal life, we all are switching to the new normal. Federation of Indian Chambers of Commerce and Industry is all set to start Global Virtual Healthcare Expo (GVHE) under flagship initiative GLOBIZ in regions like ASEAN, Africa, CIS & Russia Middle East, SAARC and South East Asia to connect Indian business houses and manufacturers with the world and ensure an impetus in exports and keep the business running.

Virtual Expo gives a completely immersive experience where the Exhibitor, Delegate or Visitor come on a virtual platform sing in their home through their handheld devices and showcase their products, do one on one meetings, have pre- fixed B2B meetings and can participate in realtime conferences or product launches or media interactions. It gives a one-stop solution from the comfort of your home to connect with your desired buyers, traders, distributors and decision-makers.

Quality of health services across the globe varies significantly, creating a broad scope of investment and engagement opportunities.

ADVANTAGE: INDIA

  • India is the largest provider of generic drugs globally. 
  • Pharma Exports stood up at US$ 19.13 billion in fiscal year2019
  • Generic drugs account for 20 per cent of global exports in terms of volume, making the country the largest provider of generic medicines globally and expected to expand even further in coming years. 
  • Emerged as a world-class, cost-effective generic drug manufacturer for drugs used for life-threatening diseases – AIDS, tuberculosis, cancer and others.
  • India has highest number of USFDA-approved plants for generic drug manufacturing outside the US.
  • Indian pharmaceutical sector is expected to grow to US$ 100 billion and medical device market expected to grow US$ 25 billion by 2025. 
  • Medical devices industry in India has been growing 15.2 per cent annually and was valued at US$ 5.2 billion in 2018 and expected to grow US$ 8.16 billion by 2020
  • The total worth of exports of AYUSH products, including extracts of medicinal herbs, has gone up to 446 million U.S. dollars from India in fiscal year 2019
FOCUSED REGIONS:
  • ASEAN
  • Africa
  • CIS
  • SAARC
  • Middle East
  • South East Asia
  • LAC
  • North America